Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification.

Grisendi V, Mastellari E, La Marca A.

Front Endocrinol (Lausanne). 2019 May 8;10:281. doi: 10.3389/fendo.2019.00281. eCollection 2019. Review.

2.

Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?

La Marca A, Capuzzo M.

Reprod Biomed Online. 2019 Mar 29. pii: S1472-6483(19)30349-9. doi: 10.1016/j.rbmo.2019.03.212. [Epub ahead of print] Review.

PMID:
31138494
3.

DNA extraction from soil by EZ1 advanced XL (Qiagen).

Barbaro A, Cormaci P, La Marca A.

Forensic Sci Int. 2019 Jun;299:161-167. doi: 10.1016/j.forsciint.2019.04.004. Epub 2019 Apr 12.

PMID:
31022675
4.

Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH).

Sacchi S, Tenedini E, Tondelli D, Parenti S, Tagliasacchi D, Xella S, Marsella T, Tagliafico E, La Marca A.

Gynecol Endocrinol. 2019 Jul;35(7):623-627. doi: 10.1080/09513590.2019.1576611. Epub 2019 Feb 20.

PMID:
30784329
5.

A novel transnational fresh oocyte donation (TOD) program based on transport of frozen sperm and embryos.

La Marca A, Dal Canto M, Buccheri M, Valerio M, Mignini Renzini M, Rodriguez A, Vassena R.

Hum Reprod. 2019 Feb 1;34(2):285-290. doi: 10.1093/humrep/dey331.

PMID:
30520998
6.

From a circle to a sphere: the ultrasound imaging of ovarian follicle with 2D and 3D technology.

Re C, Mignini Renzini M, Rodriguez A, Dal Canto M, Buccheri M, Sacchi S, Bartolucci S, Fadini R, La Marca A.

Gynecol Endocrinol. 2019 Mar;35(3):184-189. doi: 10.1080/09513590.2018.1522297. Epub 2018 Nov 3.

PMID:
30394144
7.

New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation.

Sighinolfi G, Sunkara SK, La Marca A.

Reprod Biomed Online. 2018 Oct;37(4):489-497. doi: 10.1016/j.rbmo.2018.07.006. Epub 2018 Aug 11. Review.

PMID:
30170909
8.

Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium.

Sacchi S, Sena P, Degli Esposti C, Lui J, La Marca A.

J Assist Reprod Genet. 2018 Sep;35(9):1703-1712. doi: 10.1007/s10815-018-1248-8. Epub 2018 Jul 4.

PMID:
29974367
9.

Corrigendum: Letter to the Editor: Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates.

La Marca A, Blockeel C, Bosch E, Fanchin R, Fatemi HM, Fauser BC, García-Velasco JA, Humaidan P, Tarlatzis BC, Nelson SM.

Hum Reprod. 2018 Jul 1;33(7):1372. doi: 10.1093/humrep/dey102. No abstract available.

PMID:
29718198
10.

Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency.

Huhtaniemi I, Hovatta O, La Marca A, Livera G, Monniaux D, Persani L, Heddar A, Jarzabek K, Laisk-Podar T, Salumets A, Tapanainen JS, Veitia RA, Visser JA, Wieacker P, Wolczynski S, Misrahi M.

Trends Endocrinol Metab. 2018 Jun;29(6):400-419. doi: 10.1016/j.tem.2018.03.010. Epub 2018 Apr 26. Review.

11.

Perinatal outcomes following IVF with use of donor versus partner sperm.

Kamath MS, Antonisamy B, Selliah HY, La Marca A, Sunkara SK.

Reprod Biomed Online. 2018 Jun;36(6):705-710. doi: 10.1016/j.rbmo.2018.03.016. Epub 2018 Apr 6.

PMID:
29673729
12.

Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates.

La Marca A, Blockeel C, Bosch E, Fanchin R, Fatemi HM, Fauser BC, García-Velasco JA, Humaidan P, Tarlatzis BC, Nelson SM.

Hum Reprod. 2018 May 1;33(5):982-983. doi: 10.1093/humrep/dey061. No abstract available. Erratum in: Hum Reprod. 2018 Jul 1;33(7):1372.

PMID:
29596626
13.

Ethylenediamine-N,N'-Disuccinic Acid (EDDS)-Enhanced Flushing Optimization for Contaminated Agricultural Soil Remediation and Assessment of Prospective Cu and Zn Transport.

Race M, Ferraro A, Fabbricino M, La Marca A, Panico A, Spasiano D, Tognacchini A, Pirozzi F.

Int J Environ Res Public Health. 2018 Mar 18;15(3). pii: E543. doi: 10.3390/ijerph15030543.

14.

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).

Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BWJ, Marjoribanks J, Torrance H, Broekmans FJ.

Cochrane Database Syst Rev. 2018 Feb 1;2:CD012693. doi: 10.1002/14651858.CD012693.pub2. Review.

15.

Corrigendum to "Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV" [J Hepatol 68 (2018) 33-41].

Karampatou A, Han X, Kondili LA, Taliani G, Ciancio A, Morisco F, Critelli RM, Baraldi E, Bernabucci V, Troshina G, Guarino M, Tagliavini S, D'Ambrosio F, Bristot L, Turco L, Rosato S, Vella S, Trenti T, Neri I, La Marca A, Manthena S, Goldstein AS, Bruno S, Bao Y, Gonzalez YS, Villa E; PITER framework investigators.

J Hepatol. 2018 Apr;68(4):867. doi: 10.1016/j.jhep.2018.01.004. Epub 2018 Feb 1. No abstract available.

PMID:
29366584
16.

How much variation in oocyte yield after controlled ovarian stimulation can be explained? A multilevel modelling study.

Rustamov O, Wilkinson J, La Marca A, Fitzgerald C, Roberts SA.

Hum Reprod Open. 2017 Nov 13;2017(3):hox018. doi: 10.1093/hropen/hox018. eCollection 2017.

17.

Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.

La Marca A, Minasi MG, Sighinolfi G, Greco P, Argento C, Grisendi V, Fiorentino F, Greco E.

Fertil Steril. 2017 Nov;108(5):777-783.e2. doi: 10.1016/j.fertnstert.2017.08.029. Epub 2017 Oct 4.

PMID:
28987789
18.

Last-male sperm precedence in Rhynchophorus ferrugineus (Olivier): observations in laboratory mating experiments with irradiated males.

Musmeci S, Belvedere S, Sasso R, Arnone S, Cristofaro M, Nobili P, La Marca A, De Biase A.

Bull Entomol Res. 2018 Feb;108(1):93-100. doi: 10.1017/S0007485317000840. Epub 2017 Oct 3.

PMID:
28969718
19.

How to personalize ovarian stimulation in clinical practice.

Sighinolfi G, Grisendi V, La Marca A.

J Turk Ger Gynecol Assoc. 2017 Sep 1;18(3):148-153. doi: 10.4274/jtgga.2017.0058.

20.

Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV.

Karampatou A, Han X, Kondili LA, Taliani G, Ciancio A, Morisco F, Critelli RM, Baraldi E, Bernabucci V, Troshina G, Guarino M, Tagliavini S, D'Ambrosio F, Bristot L, Turco L, Rosato S, Vella S, Trenti T, Neri I, La Marca A, Manthena S, Goldstein AS, Bruno S, Bao Y, Gonzalez YS, Villa E; PITER framework investigators; PITER Investigators.

J Hepatol. 2017 Sep 5. pii: S0168-8278(17)32259-6. doi: 10.1016/j.jhep.2017.08.019. [Epub ahead of print] Erratum in: J Hepatol. 2018 Jan 20;:.

21.

The anti-Müllerian hormone (AMH) induces forkhead box L2 (FOXL2) expression in primary culture of human granulosa cells in vitro.

Sacchi S, Marinaro F, Xella S, Marsella T, Tagliasacchi D, La Marca A.

J Assist Reprod Genet. 2017 Sep;34(9):1131-1136. doi: 10.1007/s10815-017-0980-9. Epub 2017 Jun 29.

22.

Biopsychosocial predictors of interferon-related depression in patients with Hepatitis C.

Belvederi Murri M, Cecere AC, Masotti M, Sammito G, la Marca A, Torres GV, Bonfitto I, Cuozzo E, Rossi L, Serviddio G, Villani R, Picciotto A, Bellomo A, Amore M.

Asian J Psychiatr. 2017 Apr;26:24-28. doi: 10.1016/j.ajp.2017.01.001. Epub 2017 Jan 10.

PMID:
28483085
23.

Vitamin D and ovarian reserve: making clinical decisions.

Drakopoulos P, La Marca A, Polyzos NP.

Hum Reprod. 2017 May 1;32(5):1138-1139. doi: 10.1093/humrep/dex045. No abstract available.

PMID:
28333350
24.

Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers.

Grisendi V, La Marca A.

Minerva Ginecol. 2017 Jun;69(3):250-258. doi: 10.23736/S0026-4784.17.04044-8. Epub 2017 Mar 7. Review.

PMID:
28271699
25.

A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles.

Allegra A, Marino A, Volpes A, Coffaro F, Scaglione P, Gullo S, La Marca A.

Reprod Biomed Online. 2017 Apr;34(4):429-438. doi: 10.1016/j.rbmo.2017.01.012. Epub 2017 Jan 23.

PMID:
28189417
26.

Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study.

Papaleo E, Zaffagnini S, Munaretto M, Vanni VS, Rebonato G, Grisendi V, Di Paola R, La Marca A.

Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:94-99. doi: 10.1016/j.ejogrb.2016.10.021. Epub 2016 Oct 26.

PMID:
27835829
27.

Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol.

Sacchi S, Marinaro F, Tondelli D, Lui J, Xella S, Marsella T, Tagliasacchi D, Argento C, Tirelli A, Giulini S, La Marca A.

Reprod Biol Endocrinol. 2016 Aug 31;14(1):52. doi: 10.1186/s12958-016-0189-2.

28.

The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH.

Sacchi S, D'Ippolito G, Sena P, Marsella T, Tagliasacchi D, Maggi E, Argento C, Tirelli A, Giulini S, La Marca A.

J Assist Reprod Genet. 2016 Jan;33(1):95-100. doi: 10.1007/s10815-015-0615-y. Epub 2015 Dec 2.

29.

Genetic and morphological studies of Trichosirocalus species introduced to North America, Australia and New Zealand for the biological control of thistles.

De Biase A, Colonnelli E, Belvedere S, La Marca A, Cristofaro M, Smith L.

Bull Entomol Res. 2016 Feb;106(1):99-113. doi: 10.1017/S000748531500084X. Epub 2015 Nov 9.

PMID:
26548721
30.

The use of ovarian reserve markers in IVF clinical practice: a national consensus.

La Marca A, Ferraretti AP, Palermo R, Ubaldi FM.

Gynecol Endocrinol. 2016;32(1):1-5. doi: 10.3109/09513590.2015.1102879. Epub 2015 Nov 4.

PMID:
26531067
31.

Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study.

La Marca A, Grisendi V, Giulini S, Sighinolfi G, Tirelli A, Argento C, Re C, Tagliasacchi D, Marsella T, Sunkara SK.

J Assist Reprod Genet. 2015 Jun;32(6):931-7. doi: 10.1007/s10815-015-0476-4. Epub 2015 May 1.

32.

Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes.

Sunkara SK, La Marca A, Seed PT, Khalaf Y.

Hum Reprod. 2015 Jun;30(6):1473-80. doi: 10.1093/humrep/dev076. Epub 2015 Apr 16.

PMID:
25883033
33.

The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study.

La Marca A, Grisendi V, Dondi G, Sighinolfi G, Cianci A.

Gynecol Endocrinol. 2015 Jan;31(1):52-6. doi: 10.3109/09513590.2014.964201. Epub 2014 Sep 30.

PMID:
25268566
34.

The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause.

La Marca A, Dondi G, Sighinolfi G, Giulini S, Papaleo E, Cagnacci A, Faddy MJ.

Hum Reprod. 2014 Nov;29(11):2530-5. doi: 10.1093/humrep/deu234. Epub 2014 Sep 29.

PMID:
25267784
35.

Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin.

Piomboni P, Focarelli R, Capaldo A, Stendardi A, Cappelli V, Cianci A, La Marca A, Luddi A, De Leo V.

J Assist Reprod Genet. 2014 Oct;31(10):1269-76. doi: 10.1007/s10815-014-0307-z. Epub 2014 Aug 12.

36.

Reply: The two sides of the individualization of controlled ovarian stimulation.

La Marca A, Sunkara SK.

Hum Reprod Update. 2014 Jul-Aug;20(4):614-5. No abstract available.

PMID:
25093217
37.

FSHR polymorphism p.N680S mediates different responses to FSH in vitro.

Casarini L, Moriondo V, Marino M, Adversi F, Capodanno F, Grisolia C, La Marca A, La Sala GB, Simoni M.

Mol Cell Endocrinol. 2014 Aug 5;393(1-2):83-91. doi: 10.1016/j.mce.2014.06.013. Epub 2014 Jun 23.

PMID:
24970684
38.

Recombinant LH administration in subsequent cycle after "unexpected" poor response to recombinant FSH monotherapy.

Papaleo E, Vanni VS, Viganò P, La Marca A, Pagliardini L, Vitrano R, Zanirato M, Marsiglio E, Privitera L, Candiani M.

Gynecol Endocrinol. 2014 Nov;30(11):813-6. doi: 10.3109/09513590.2014.932342. Epub 2014 Jun 26.

PMID:
24968088
39.

The role of ovarian suspension in endometriosis surgery: a randomized controlled trial.

Seracchioli R, Di Donato N, Bertoldo V, La Marca A, Vicenzi C, Zannoni L, Villa G, Monti G, Leonardi D, Giovanardi G, Venturoli S, Montanari G.

J Minim Invasive Gynecol. 2014 Nov-Dec;21(6):1029-35. doi: 10.1016/j.jmig.2014.04.016. Epub 2014 May 16.

PMID:
24842806
40.

Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.

Stabile G, Borrielli I, Artenisio AC, Bruno LM, Benvenga S, Giunta L, La Marca A, Volpe A, Pizzo A.

J Pediatr Adolesc Gynecol. 2014 Jun;27(3):177-82. doi: 10.1016/j.jpag.2013.09.015.

PMID:
24814528
41.

Age-specific reference values for serum FSH and estradiol levels throughout the reproductive period.

Grisendi V, Spada E, Argento C, Plebani M, Milani S, Seracchioli R, Volpe A, La Marca A.

Gynecol Endocrinol. 2014 Jun;30(6):451-5. doi: 10.3109/09513590.2014.893572. Epub 2014 May 7.

PMID:
24805832
42.

The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropin.

Arce JC, Klein BM, La Marca A.

Gynecol Endocrinol. 2014 Jun;30(6):444-50. doi: 10.3109/09513590.2014.892066. Epub 2014 Feb 27.

43.

Basal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles.

Papaleo E, Corti L, Vanni VS, Pagliardini L, Ottolina J, De Michele F, La Marca A, Viganò P, Candiani M.

Arch Gynecol Obstet. 2014 Jul;290(1):169-76. doi: 10.1007/s00404-014-3167-y. Epub 2014 Feb 19.

PMID:
24549270
44.

Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients.

Ventriglio A, Gentile A, Baldessarini RJ, Martone S, Vitrani G, La Marca A, Bellomo A.

Eur Psychiatry. 2014 Sep;29(7):402-7. doi: 10.1016/j.eurpsy.2013.11.005. Epub 2014 Jan 16.

PMID:
24439513
45.

The physiology and clinical utility of anti-Mullerian hormone in women.

Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA.

Hum Reprod Update. 2014 May-Jun;20(3):370-85. doi: 10.1093/humupd/dmt062. Epub 2014 Jan 14. Review. Erratum in: Hum Reprod Update. 2014 Sep-Oct;20(5):804.

PMID:
24430863
46.

Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction.

La Marca A, D'Ippolito G.

Reprod Biomed Online. 2014 Feb;28(2):183-90. doi: 10.1016/j.rbmo.2013.10.012. Epub 2013 Oct 25. Review.

PMID:
24368127
47.

How Much Does AMH Really Vary in Normal Women?

La Marca A, Grisendi V, Griesinger G.

Int J Endocrinol. 2013;2013:959487. doi: 10.1155/2013/959487. Epub 2013 Nov 19. Review.

48.

Evaluation of the accuracy and ease of use of a rapid HIV-1 Antibody Test performed by untrained operators at the point of care.

Galli RA, Green KF, La Marca A, Waldman LF, Powers RE, Daly AC, Shackleton CR.

J Clin Virol. 2013 Dec;58 Suppl 1:e65-9. doi: 10.1016/j.jcv.2013.08.024.

PMID:
24342479
49.

Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period.

La Marca A, Grisendi V, Spada E, Argento C, Milani S, Plebani M, Seracchioli R, Volpe A.

Gynecol Endocrinol. 2014 Jan;30(1):66-9. doi: 10.3109/09513590.2013.854768. Epub 2013 Dec 4.

PMID:
24303886
50.

Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.

La Marca A, Sunkara SK.

Hum Reprod Update. 2014 Jan-Feb;20(1):124-40. doi: 10.1093/humupd/dmt037. Epub 2013 Sep 29. Review.

PMID:
24077980

Supplemental Content

Support Center